As players use the tablet to scan their 360° surroundings, they are tasked with identifying abnormal residual plasma cells. In addition, educational screens at the start and conclusion of reach round, plus quiz questions, reinforce key learnings.
Completing the experience creates a greater understanding of the characteristics of treatment-resistant cells and importance of testing for minimal residual disease in multiple myeloma (MM) patients to improve outcomes.

You may also like

Back to Top